170 related articles for article (PubMed ID: 36034099)
1. Management System Approach for Addressing Biosafety and Biosecurity of Emerging Pathogens in a Biosafety Level-3 Core Facility.
Joseph T
Appl Biosaf; 2021 Dec; 26(4):210-220. PubMed ID: 36034099
[No Abstract] [Full Text] [Related]
2. Biorisk Management for SARS-CoV-2 Research in a Biosafety Level-3 Core Facility.
Joseph T; Phyu S; Se-Thoe SY; Chu JJH
Methods Mol Biol; 2022; 2452():441-464. PubMed ID: 35554920
[TBL] [Abstract][Full Text] [Related]
3. Strengthening Biorisk Management in Research Laboratories with Security-Sensitive Biological Agents Like SARS-CoV-2.
Phyu S; Joseph T; Goulart M
Methods Mol Biol; 2022; 2452():395-439. PubMed ID: 35554919
[TBL] [Abstract][Full Text] [Related]
4. Mobile High-Containment Biological Laboratories Deployment: Opportunities and Challenges in Expeditionary Deployments to Outbreak Response.
Rao V; Bordelon E
Appl Biosaf; 2019 Mar; 24(1):20-29. PubMed ID: 36034633
[TBL] [Abstract][Full Text] [Related]
5. Assessment of biorisk management systems in high containment laboratories, 18 countries in Europe, 2016 and 2017.
Appelt S; Jacob D; Rohleder AM; Bråve A; Szekely Björndal Å; Di Caro A; Grunow R;
Euro Surveill; 2020 Sep; 25(36):. PubMed ID: 32914748
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the Biosafety and Biosecurity Landscape in the Philippines and the Development of the National Biorisk Management Framework.
Destura RV; Lam HY; Navarro RC; Lopez JCF; Sales RKP; Gomez MIFA; Dela Tonga A; Ulanday GE
Appl Biosaf; 2021 Dec; 26(4):232-244. PubMed ID: 36034094
[No Abstract] [Full Text] [Related]
7. The Biosafety Research Road Map: The Search for Evidence to Support Practices in Human and Veterinary Laboratories.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Bennett AM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):64-71. PubMed ID: 37342514
[TBL] [Abstract][Full Text] [Related]
8. Managing Biorisk Linked to Rapidly Expanding SARS-CoV-2 Research.
Vijayan V
Appl Biosaf; 2020 Sep; 25(3):132-133. PubMed ID: 36035762
[No Abstract] [Full Text] [Related]
9. Biosafety and biosecurity capacity building: insights from implementation of the NUITM-KEMRI biosafety training model.
Muriithi B; Bundi M; Galata A; Miringu G; Wandera E; Kathiiko C; Odoyo E; Kamemba M; Amukoye E; Huqa S; Shah M; Inoue S; Ichinose Y
Trop Med Health; 2018; 46():30. PubMed ID: 30116141
[TBL] [Abstract][Full Text] [Related]
10. A Multilingual Tool for Standardized Laboratory Biosafety and Biosecurity Assessment and Monitoring.
Orelle A; Nikiema A; Zakaryan A; Albetkova AA; Keita MS; Rayfield MA; Peruski LF; Pierson A
Health Secur; 2022; 20(6):488-496. PubMed ID: 36383124
[TBL] [Abstract][Full Text] [Related]
11. A Cross-Sectional Survey to Assess Biorisk Management System in Research and Diagnostic Laboratories in Khyber Pakhtunkhwa, Pakistan.
Muhammad J; Sarwar S; Khan T; Qasmi SA; Ikram A; Ahmad G; Zahid M; Durrani RH; Ahmed F
Front Public Health; 2021; 9():766162. PubMed ID: 34976925
[TBL] [Abstract][Full Text] [Related]
12. The Biosafety Research Road Map: The Search for Evidence to Support Practices in the Laboratory-SARS-CoV-2.
Blacksell SD; Dhawan S; Kusumoto M; Le KK; Summermatter K; O'Keefe J; Kozlovac J; Almuhairi SS; Sendow I; Scheel CM; Ahumibe A; Masuku ZM; Kojima K; Harper DR; Hamilton K
Appl Biosaf; 2023 Jun; 28(2):87-95. PubMed ID: 37342515
[TBL] [Abstract][Full Text] [Related]
13. Harmonization of Biosafety and Biosecurity Standards for High-Containment Facilities in Low- and Middle-Income Countries: An Approach From the Perspective of Occupational Safety and Health.
Maehira Y; Spencer RC
Front Public Health; 2019; 7():249. PubMed ID: 31572701
[TBL] [Abstract][Full Text] [Related]
14. [Biorisk Management for Clinical Diagnostic Laboratories].
Shigematsu M
Rinsho Byori; 2016 Nov; 64(11):1279-1289. PubMed ID: 30695310
[TBL] [Abstract][Full Text] [Related]
15. Significance of High-Containment Biological Laboratories Performing Work During the COVID-19 Pandemic: Biosafety Level-3 and -4 Labs.
Yeh KB; Tabynov K; Parekh FK; Mombo I; Parker K; Tabynov K; Bradrick SS; Tseng AS; Yang JR; Gardiner L; Olinger G; Setser B
Front Bioeng Biotechnol; 2021; 9():720315. PubMed ID: 34485259
[TBL] [Abstract][Full Text] [Related]
16. Biosafety and biosecurity measures: management of biosafety level 3 facilities.
Zaki AN
Int J Antimicrob Agents; 2010 Nov; 36 Suppl 1():S70-4. PubMed ID: 20801002
[TBL] [Abstract][Full Text] [Related]
17. Highlights of Biosafety and Biosecurity Month (BBM)at the AIMST University and Perspectives on Biorisk Management.
Bhore SJ
Bioinformation; 2019; 15(8):568-571. PubMed ID: 31719766
[TBL] [Abstract][Full Text] [Related]
18. Assessment of the Biosafety and Biosecurity in the Reference Veterinary Laboratory of Parakou in Benin.
Sodjinou VD; Ayelo PA; Achade AGA; Affolabi D; Ouendo DE
Trop Med Infect Dis; 2021 Aug; 6(3):. PubMed ID: 34449734
[TBL] [Abstract][Full Text] [Related]
19. [Developing a Biosafety Level 4 Laboratory user training program].
Nanbo A; Urata S; Tsuda Y
Uirusu; 2022; 72(2):125-130. PubMed ID: 38220156
[TBL] [Abstract][Full Text] [Related]
20. ANSI/ASSP Z9.14-2020 Testing and Performance-Verification Methodologies for Biosafety Level 3 (BSL-3) and Animal Biosafety Level 3 (ABSL-3) Ventilation Systems.
Memarzadeh F
Appl Biosaf; 2020 Dec; 25(4):181-183. PubMed ID: 36032391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
